Recent developments to share with you

"United Efforts, Self-Surpassing, Focus on Innovation, Striving for Excellence" – Kangchuanji Team Building Event

2022-09-12


Bathed in the spring morning sun and the fresh scent of dew, all colleagues of Kangchuanji gathered on April 18, 2021, at the Yufa Ecological Park in Pukou for a oneday team building activity. The theme of the event was "United Efforts, SelfSurpassing, Focus on Innovation, Striving for Excellence." The Human Resources department, together with the team building company, carefully planned a series of collaborative exercises, including obstacle course on spike mats, Da Vinci Code, aerial drone formation of the company logo, and a team energy circle. These activities showcased a fresh, youthful, and spirited team culture.

Keywords:

Related information

Bountiful Results | January–July 2026: Kangchuanji Pharmaceutical, in collaboration with multiple pharmaceutical companies, secured approval or passed the evaluation for 15 product specifications.

From January to July 2026, Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd., leveraging its deep-rooted pharmaceutical R&D expertise and mature end-to-end CDMO capabilities, has provided robust support for the innovative R&D and commercialization of its partner companies, achieving further regulatory‑review milestones in collaboration with multiple partners. According to the NMPA’s public announcement of drug approval documents, a total of 12 drug products (covering 15 specifications) have been successfully approved or passed consistency evaluation, demonstrating significant results in translating innovative research into tangible outcomes.

2026-08-04

CDE Announcement: Updated Guidelines for Pediatric Medicines! “Technical Guidance on the Application of Physiologically Based Pharmacokinetic Models in Drug Development for Pediatric Populations (Draft for Public Comment)”

On August 17, the CDE released a draft of the “Technical Guidance for the Application of Physiologically Based Pharmacokinetic Models in Pediatric Drug Development” for public comment.

2024-10-27

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

2026-07-03